News
This article was written by Seeking Alpha’s transcripts team is responsible for the development of all of our transcript-related projects. We currently publish thousands...
Hi, what are you looking for?
iFintechWorld
iFintechWorld
News
This article was written by Follow For almost a decade, I held research analyst positions in various investment firms, mostly in Toronto. In the...
News
This article was written by Follow I am an individual investor that is now fully focus on managing my own capital that I have...
News
This article was written by Follow I’m a full-time analyst and portfolio manager of a technology fund with 5 years of experience. I graduated...
News
This article was written by Seeking Alpha’s transcripts team is responsible for the development of all of our transcript-related projects. We currently publish thousands...
News
The S&P 500 has continued its rally, but sentiment has not exactly reflected that. The latest reading on investor sentiment from the AAII survey...
News
Boyd Gaming Corporation (NYSE:BYD) Q2 2023 Earnings Conference Call July 27, 2023 5:00 PM ET Company Participants David Strow – VP, Corporate Communications Keith...
News
Hub Group, Inc. (NASDAQ:HUBG) Q2 2023 Earnings Conference Call July 27, 2023 5:00 PM ET Company Participants Phil Yeager – President and Chief Executive...
News
Integer Holdings Corporation (NYSE:ITGR) Q2 2023 Earnings Conference Call July 27, 2023 9:00 AM ET Company Participants Joe Dziedzic – President and Chief Executive...
News
This article is reprinted by permission from The Escape Home, a newsletter for second homeowners and those who want to be. Subscribe here. ©...
News
Exponent, Inc. (NASDAQ:EXPO) Q2 2023 Earnings Conference Call July 27, 2023 4:30 PM ET Company Participants Joni Konstantelos – Investor Relations Dr. Catherine Corrigan...
News
The lovely New York City townhouse of the late Stephen Sondheim, revered Broadway composer and lyricist, has just been listed for $7 million, according to Architectural Digest. Set...
News
Introduction UroGen Pharma (NASDAQ:URGN) is a biotech company focused on developing innovative solutions for urothelial and specialty cancers. They’ve developed RTGel, a proprietary reverse-thermal...
